Your browser is no longer supported. Please, upgrade your browser.
Settings
STJ St. Jude Medical Inc. daily Stock Chart
STJ [NYSE]
St. Jude Medical Inc.
IndexS&P 500 P/E33.98 EPS (ttm)2.30 Insider Own0.10% Shs Outstand284.24M Perf Week-5.59%
Market Cap22.24B Forward P/E17.70 EPS next Y4.42 Insider Trans0.00% Shs Float277.96M Perf Month-5.77%
Income661.00M PEG3.11 EPS next Q1.01 Inst Own83.40% Short Float3.18% Perf Quarter0.27%
Sales5.80B P/S3.84 EPS this Y-11.10% Inst Trans-2.60% Short Ratio2.97 Perf Half Y45.98%
Book/sh15.06 P/B5.20 EPS next Y8.90% ROA5.40% Target Price78.97 Perf Year9.82%
Cash/sh1.40 P/C55.88 EPS next 5Y10.92% ROE16.10% 52W Range48.35 - 84.00 Perf YTD27.93%
Dividend1.24 P/FCF43.87 EPS past 5Y2.30% ROI9.30% 52W High-6.85% Beta1.32
Dividend %1.58% Quick Ratio1.20 Sales past 5Y1.40% Gross Margin67.10% 52W Low61.83% ATR1.26
Employees18000 Current Ratio1.70 Sales Q/Q10.80% Oper. Margin16.10% RSI (14)25.82 Volatility3.74% 1.35%
OptionableYes Debt/Eq1.42 EPS Q/Q-18.70% Profit Margin11.40% Rel Volume3.07 Prev Close78.01
ShortableYes LT Debt/Eq1.27 EarningsJul 20 BMO Payout51.40% Avg Volume2.97M Price78.25
Recom3.00 SMA20-5.47% SMA50-3.20% SMA20018.11% Volume9,109,466 Change0.31%
Jul-21-16Reiterated Barclays Equal Weight $80 → $83
Jul-15-16Downgrade Wedbush Outperform → Neutral $70 → $84
Jul-11-16Downgrade Leerink Partners Outperform → Mkt Perform
May-10-16Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
May-03-16Downgrade Credit Suisse Outperform → Neutral
May-02-16Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-29-16Downgrade Needham Buy → Hold
Apr-28-16Downgrade Piper Jaffray Overweight → Neutral
Mar-17-16Initiated Nomura Buy
Feb-08-16Upgrade Canaccord Genuity Sell → Hold $54
Jan-28-16Reiterated Oppenheimer Perform $72 → $64
Jan-25-16Reiterated RBC Capital Mkts Sector Perform $66 → $57
Jan-19-16Downgrade Wells Fargo Outperform → Market Perform
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy
Oct-22-15Reiterated RBC Capital Mkts Sector Perform $75 → $66
Oct-22-15Downgrade Stifel Buy → Hold
Jul-23-15Reiterated Stifel Buy $81 → $89
Jul-23-15Reiterated RBC Capital Mkts Sector Perform $71 → $75
Jul-23-15Reiterated Barclays Overweight $84 → $86
Jul-23-15Downgrade Deutsche Bank Buy → Hold $76 → $77
Aug-29-16 05:07PM  Muddy Waters Short Seller Carson Block Takes on St. Jude at Investopedia
01:10PM  An Outside View on St. Jude Device Cyberattack Woes at 24/7 Wall St.
12:06PM  ETFs with exposure to St. Jude Medical, Inc. : August 29, 2016
Aug-26-16 06:38PM  Whiplashed investors stay skittish about St. Jude Reuters
05:26PM  [$$] St. Jude Denies Claims in Muddy Waters Report at The Wall Street Journal
04:43PM  St. Jude (STJ) Faces Long-Term Risks, Muddy Waters' Block Tells CNBC
04:24PM  St. Jude Medical Rejects Short-Sellers Allegations
04:21PM  Muddy Waters' Carson Block says St. Jude Medical shares could fall to $55 at CNBC
04:17PM  Shares of St. Jude Medical resume trading, recover losses at CNBC
03:43PM  St. Jude reopens
03:35PM  St. Jude Medical Refutes Muddy Waters Device Security Allegations and Reinforces Security of Devices and Commitment to Patient Safety Business Wire
03:30PM  St. Jude (STJ) Stock Down Despite Response to Muddy Waters Allegations
03:06PM  St. Jude halted for news
10:47AM  St. Jude Medical (STJ) Stock Down, Credit Suisse: Shares Likely to Remain Pressured
08:17AM  Early movers: HLF, AAPL, TSLA, SCTY, VIAB, PSTG & more at CNBC
08:12AM  St. Jude Medical, Inc. breached its 50 day moving average in a Bearish Manner : STJ-US : August 26, 2016
Aug-25-16 07:47PM  [$$] Muddy Waters-St Jude: heart attack at Financial Times
04:55PM  Medtronic Misses High Expectations; St. Jude Dives On Hacking Claim
04:49PM  Pitts: Carson Block's St. Jude Comments Are a Market Play
04:43PM  St. Jude Medical drops after Muddy Water findings of 'negligent product design' at CNBC
03:59PM  MedSec CEO Responds to Carson Block's St. Jude Comments
02:05PM  St. Jude devices are easy targets for hackers, short-seller says (Video) at bizjournals.com
12:52PM  Will MedSec's St.Jude Claims Impact Abbott Deal?
12:35PM  MedSec's Bone: Hope St. Jude Responds With Urgency
12:31PM  Bone: St. Jude Has History of Sweeping Things Under Table
12:13PM  Markets React to Muddy Waters Short of St. Jude
12:06PM  St. Jude: Several Layers of Security in Place
12:00PM  St. Jude (STJ) Stock Drops, Muddy Waters Shorts on Security Flaw
11:27AM  St. Jude Medical's stock drops after short seller Muddy Waters takes aim at MarketWatch
11:01AM  Block Bets St. Jude Security Flaw Will Derail Abbott Deal
10:58AM  Carson Block Shorts St. Jude on Hack Threat
Aug-24-16 05:50PM  Top 10 Stocks Hedge Funds Bought and Sold in Q2 (HOT, STJ) at Investopedia
08:41AM  Medtronic Earnings Face FX Headwinds, But Cardiac Trends Good
Aug-22-16 11:00AM  Kessler Topaz Meltzer & Check, LLP and Motley Rice LLC Announce Proposed Settlement of Class Action Lawsuit Involving Purchasers of St. Jude Medical, Inc. Common Stock PR Newswire
Aug-18-16 04:30PM  A Look at Boston Scientifics Latest Valuation
04:05PM  John Rogers Comments on Abbott Laboratories
Aug-15-16 04:25PM  Hedge funds made big changes at drug companies in 2nd qtr -filings
Aug-12-16 12:41PM  Barclays Says Investors Underestimate St. Jude Medical 's Potential
Aug-10-16 01:04PM  ST JUDE MEDICAL INC Financials
Aug-08-16 02:44PM  ETFs with exposure to St. Jude Medical, Inc. : August 8, 2016
Aug-03-16 04:25PM  ST JUDE MEDICAL INC Files SEC form 10-Q, Quarterly Report
04:15PM  St. Jude Medical Announces Third Quarter Dividend Business Wire
01:51AM  St. Jamess Place Plc :STJ-GB: Earnings Analysis: For the six months ended June 30, 2016 : August 3, 2016
Jul-29-16 12:58PM  Boston Scientifics Stock Surged after 2Q16 Earnings
11:17AM  C.R. Bards Vascular Segment Flowing Well despite Tougher Comps
11:17AM  C.R. Bard Registered Strong 2Q16 Performance, Beat Estimates
06:38AM  Did Baxter International Beat 2Q16 Earnings Estimates?
Jul-22-16 05:22PM  Johnson & Johnson Reports 4% Sales Growth for the Second Quarter
03:25PM  ETFs with exposure to St. Jude Medical, Inc. : July 22, 2016
01:28PM  St. Jude Medical Gets Hold Rating from 96% of Analysts
01:28PM  How St. Jude Medical Beat 2Q16 Wall Street Estimates
08:55AM  Did Hedge Funds Anticipate These M&A Deals? at Insider Monkey
07:29AM  R&D Investments, Product Launches Key to Abbotts 2Q Performance
Jul-21-16 11:34AM  St. Jude Medical, Inc. :STJ-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016
06:05AM  A Look at Ingersoll Rand Stock ahead of 2Q16 Earnings
Jul-20-16 05:16PM  WeissLaw LLP Files Class Action Lawsuit Against St. Jude Medical, Inc. PR Newswire
03:06PM  [$$] Abbott Labs Profit Tops Views at The Wall Street Journal
12:55PM  Abbott's Alere Deal Continues To Face Uncertainty
12:15PM  Edited Transcript of STJ earnings conference call or presentation 20-Jul-16 12:00pm GMT
11:41AM  St. Jude Medical, Stepan Company & Three Other Stocks Trending on Strong Quarterly Results at Insider Monkey
10:40AM  [$$] St. Jude Medical Logs Double-Digit Sales Growth at The Wall Street Journal
10:12AM  St. Jude Medical (STJ) Meets Q2 Earnings, Withdraws Outlook
09:31AM  St. Jude Medical Up Slightly as It Meets Estimates
09:26AM  Abbott sales beat on higher demand for medical devices
08:42AM  St. Jude Medical's (STJ) Q2 Earnings In Line, Sales Beat
08:22AM  5 Merger Arb Plays Added to Havens Advisors Portfolio in Q2 at Insider Monkey
07:44AM  St. Jude Medical Reports In Line Q2 Results
07:26AM  ST JUDE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:15AM  St. Jude Medical Reports Second Quarter 2016 Results Business Wire
07:07AM  Q2 2016 St. Jude Medical Inc Earnings Release - Before Market Open
Jul-19-16 02:45PM  St. Jude Medical (STJ) Stock Lower Ahead of Q2 Results
09:25AM  Medical Product Earnings on Jul 20: STJ, MDSO, BABY
09:06AM  What to Expect from St. Jude Medicals Earnings in 2Q16
Jul-18-16 05:05PM  4 Big-Cap Medical Device Stocks Reporting Earnings This Week
12:07PM  4 Big-Cap Medical Device Stocks Reporting Earnings This Week
10:07AM  A Look at St. Jude Medicals 2Q16 Revenue Estimates
Jul-15-16 04:15PM  Analyst Sees No Major Concerns on Regulatory Front for Abbott-St. Jude Medical Deal
03:43PM  St. Jude Medical (STJ) Q2 Earnings: What's in the Cards?
10:29AM  Analysts Ratings of St. Jude Medical before 2Q16 Results
07:39AM  St. Jude Medical downgraded by Wedbush
Jul-14-16 06:40PM  Cramer: Clear cut winning stocks for the second half of 2016 at CNBC
09:30AM  Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
Jul-13-16 09:26AM  Heres Why Amazon, Tesla, and Three Other Stocks Are Trending Today at Insider Monkey
06:24AM  [$$] Abbott Labs Can Reap Upside Without Alere at Barrons.com
Jul-12-16 05:25PM  FTC seeks more info on Abbott-St. Jude deal Reuters
05:09PM  ST JUDE MEDICAL INC Files SEC form 8-K, Other Events
Jul-11-16 11:32AM  St. Jude Medical (STJ) Stock Downgraded at Leerink
08:00AM  St. Jude Medical Continues to Expand its Heart Failure Portfolio in the U.S. to Provide Physicians Additional Options for Managing Patients Not Responding to Other Therapies Business Wire
Jul-08-16 12:30PM  St Jude in $39.25 mln shareholder settlement over heart devices
Jul-07-16 09:58AM  Abbott Labs' Absorb Stent Gets Regulatory Approval in U.S.
Jul-05-16 01:10PM  Abbott deal for St. Jude spurs company split talk
Jun-30-16 05:35PM  GNC Holdings' Overseas Prospects Robust Amid Market Woes
12:38PM  ETFs with exposure to St. Jude Medical, Inc. : June 30, 2016
Jun-28-16 02:05PM  St. Jude Medical, Inc. :STJ-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
08:00AM  St. Jude Medical Announces Second Quarter 2016 Earnings Conference Call Business Wire
Jun-27-16 04:07PM  Medtronic Rounds Out Heart-Failure Offerings With HeartWare Buy
09:04AM  All aboard the Moat Investing Train!
Jun-23-16 08:00AM  St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies Business Wire
Jun-22-16 08:26AM  Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Jun-20-16 08:00AM  St. Jude Medical HeartMate 3 Left Ventricular Assist System Wins CARDIOSTIM-EHRA EUROPACE Innovation Award Business Wire
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients with tachycardia. It also provides atrial fibrillation products comprising electrophysiology, introducers and catheters, advanced cardiac mapping, navigation and recording systems, and ablation systems; and pacemakers, which deliver low-voltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, percutaneous catheter introducers, diagnostic guidewires, heart failure monitoring devices, renal denervation technology and vascular plugs, optical coherence tomography imaging products, and other vascular accessories, as well as CardioMEMS, a heart failure monitoring device. Further, it provides structural heart products, including heart valve replacement and repair products, and structural heart defect devices; neuromodulation products, such as spinal cord stimulation and radiofrequency ablation to treat chronic pain, as well as deep brain stimulation to treat movement disorders; and thoratec products comprising ventricular assist devices and percutaneous heart pumps. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fecho JeffVP, Global QualityJan 27Option Exercise35.277,075249,5358,912Jan 29 04:51 PM
ROCCA MICHAEL ADirectorMay 03Option Exercise40.938,800360,18430,009May 05 04:09 PM
DEVENUTI RICHARD RDirectorMay 02Option Exercise40.938,800360,18439,630May 04 04:03 PM
ESSIG STUARTDirectorApr 22Option Exercise40.938,800360,18445,099Apr 26 04:25 PM
Fecho JeffVP, Global QualityFeb 05Option Exercise35.1710,408366,05712,816Feb 09 04:17 PM
Fecho JeffVP, Global QualityFeb 05Sale51.7110,408538,1985,741Feb 09 04:17 PM
HILL BARBARA BDirectorFeb 03Option Exercise40.938,800360,18429,185Feb 05 04:24 PM
WIDENSOHLER STEFAN KDirectorFeb 01Option Exercise40.938,800360,18431,288Feb 03 04:35 PM
Zurbay DonaldVP Finance and CFODec 21Sale60.963,106189,34219,284Dec 22 04:00 PM
HEINMILLER JOHN CExecutive Vice PresidentDec 18Sale61.168,009489,830237,211Dec 22 04:01 PM
Thome ScottVP, Global Ops & Supply ChainNov 02Option Exercise41.652,999124,9083,354Nov 04 04:59 PM
Zellers JasonVP, General Counsel & Corp SecNov 02Option Exercise34.9613,333466,12223,388Nov 04 05:03 PM
Thome ScottVP, Global Ops & Supply ChainNov 02Sale64.354,595295,690355Nov 04 04:59 PM
Zellers JasonVP, General Counsel & Corp SecNov 02Sale64.2913,333857,17910,055Nov 04 05:03 PM
Zellers JasonVP, General Counsel & Corp SecOct 31Sale64.6629419,01010,055Nov 04 05:03 PM
STARKS DANIEL JChairman, CEO & PresidentOct 28Option Exercise40.55120,0004,866,0006,232,363Oct 30 04:31 PM
STARKS DANIEL JChairman, CEO & PresidentOct 28Sale62.36120,0007,483,3916,112,363Oct 30 04:31 PM
Fecho JeffVP, Global QualityOct 26Option Exercise44.6375033,4734,403Oct 28 04:31 PM
Fecho JeffVP, Global QualityOct 26Sale62.9075047,1753,653Oct 28 04:31 PM